Table 3.

Pathological and multidisciplinary discussion diagnosis in patients underwent TBLB and TBLC

Pathological diagnosis (n = 17)	n (%)
Patients underwent TBLB
Organizing pneumonia	9 (52.9)
Acute exacerbation of interstitial lung disease	3 (17.6)
Pulmonary adenocarcinoma	2 (11.8)
Lymphoma	1 (5.9)
Acute eosinophilic pneumonia	1 (5.9)
Pneumocystis jirovecii pneumonia	1 (5.9)
Multidisciplinary discussion diagnosis (n = 25)
Connective tissue disease associated interstitial lung disease	9 (36.0)
Acute exacerbation of interstitial lung disease	6 (24.0)
Cryptogenic organizing pneumonia	2 (8.0)
Pulmonary adenocarcinoma	2 (8.0)
Lymphoma	1 (4.0)
Acute eosinophilic pneumonia	1 (4.0)
Acute lung injury	1 (4.0)
Drug induced lung injury	1 (4.0)
Pneumocystis jirovecii pneumonia	1 (4.0)
Adenovirus pneumonia	1 (4.0)

Patients underwent TBLC	n (%)
Pathological diagnosis (n = 18)
Organizing pneumonia	7 (38.9)
Diffuse alveolar damage	6 (33.3)
Aspiration pneumonia	1 (5.6)
Lymphoma	1 (5.6)
Acute fibrinous organizing pneumonia	1 (5.6)
Acute exacerbation of interstitial lung disease	1 (5.6)
Cytomegalovirus pneumonia	1 (5.6)
Multidisciplinary discussion diagnosis (n = 21)
Secondary organizing pneumonia	3 (14.3)
Acute exacerbation of interstitial lung disease	3 (14.3)
Connective tissue disease associated interstitial lung disease	2 (9.5)
Aspiration pneumonia	2 (9.5)
Cryptogenic organizing pneumonia	2 (9.5)
Graft versus host disease	2 (9.5)
Acute lung injury	1 (4.8)
Acute fibrinous organizing pneumonia	1 (4.8)
Drug induced lung injury	1 (4.8)
Lymphoma	1 (4.8)
Acute reject reaction after lung transplantation	1 (4.8)
Cytomegalovirus pneumonia	1 (4.8)
Coronavirus pneumonia	1 (4.8)